Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload-Reference-Cited by-同舟云学术

Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload

Published:2016-03-01 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Bernardo Bianca C.,Nguyen Sally S.,Gao Xiao-Ming,Tham Yow Keat,Ooi Jenny Y. Y.,Patterson Natalie L.,Kiriazis Helen,Su Yidan,Thomas Colleen J.,Lin Ruby C. Y.,Du Xiao-Jun,McMullen Julie R.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep22442.pdf

Reference42 articles.

1. Braunwald, E. The war against heart failure: the Lancet lecture. The Lancet 385, 812–824 (2015).

2. Levy, D. et al. Long-term trends in the incidence of and survival with heart failure. N. Engl. J. Med. 347, 1397–1402 (2002).

3. Liu, L. & Eisen, H. J. Epidemiology of Heart Failure and Scope of the Problem. Cardiol. Clin. 32, 1–8 (2014).

4. Lin, R. C. Y. et al. PI3K(p110a) protects against myocardial infarction-induced heart failure/ Identification of PI3K-regulated miRNAs and mRNAs. Arterioscler. Thromb. Vasc. Biol. 30, 724–732 (2010).

5. McMullen, J. R. et al. Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proc. Natl. Acad. Sci. USA 104, 612–617 (2007).

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated Analysis of lncRNA–miRNA–mRNA Regulatory Network in Rapamycin-Induced Cardioprotection against Ischemia/Reperfusion Injury in Diabetic Rabbits;Cells;2023-12-12

2. The Role of miRNA in Renal Fibrosis Leading to Chronic Kidney Disease;Biomedicines;2023-08-23

3. Lipids regulated by exercise and phosphoinositide 3-kinase: potential role as biomarkers and therapeutic targets for cardiovascular disease;Current Opinion in Physiology;2023-04

4. In Vivo Inhibition of miR-34a Modestly Limits Cardiac Enlargement and Fibrosis in a Mouse Model with Established Type 1 Diabetes-Induced Cardiomyopathy, but Does Not Improve Diastolic Function;Cells;2022-10-03

5. Small non-coding RNA therapeutics for cardiovascular disease;European Heart Journal;2022-09-15